U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06864793) titled 'Study on the Pharmacokinetics and Safety of QL1012D and Gonal-F(R) in Healthy Female Volunteers' on March 04.
Brief Summary: The goal of this Interventional study is to Compare the Pharmacokinetics and Safety of Recombinant Human Follicle Stimulating Hormone Injection (QL1012D) and Gonal-F(R) in Healthy Female Volunteers. It aims to evaluate the bioequivalence of recombinant human follicle stimulating hormone injection (QL1012D) and Gonal-F(R), both given subcutaneously.
Study Start Date: May, 2025
Study Type: INTERVENTIONAL
Condition:
Infertility, Female
Intervention:
DRUG: QL1012D
A single Subcutaneous injection, 225IU
Rec...